|
SYF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.952100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.781000E-01 |
| Normal-vs-Stage2 |
2.224800E-01 |
| Normal-vs-Stage3 |
5.001900E-03 |
| Normal-vs-Stage4 |
7.793500E-04 |
| Stage1-vs-Stage2 |
1.284220E-01 |
| Stage1-vs-Stage3 |
1.138770E-03 |
| Stage1-vs-Stage4 |
6.21539999999809E-05 |
| Stage2-vs-Stage3 |
4.958000E-01 |
| Stage2-vs-Stage4 |
2.549600E-01 |
| Stage3-vs-Stage4 |
4.961600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.046500E-02 |
| Normal-vs-AfricanAmerican |
7.406600E-01 |
| Normal-vs-Asian |
5.472000E-01 |
| Caucasian-vs-AfricanAmerican |
1.426750E-01 |
| Caucasian-vs-Asian |
9.303600E-01 |
| AfricanAmerican-vs-Asian |
6.183800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.269770E-01 |
| Normal-vs-Female |
1.370210E-01 |
| Male-vs-Female |
9.180200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.858600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.486400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.877500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.166500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.346200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.801000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.303900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.605200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.816400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.807670E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.464100E-02 |
| Normal-vs-Grade 2 |
1.107180E-01 |
| Normal-vs-Grade 3 |
4.004400E-04 |
| Normal-vs-Grade 4 |
4.08619999947568E-07 |
| Grade 1-vs-Grade 2 |
1.734150E-01 |
| Grade 1-vs-Grade 3 |
3.89920000000155E-05 |
| Grade 1-vs-Grade 4 |
1.618910E-03 |
| Grade 2-vs-Grade 3 |
3.71140007615622E-10 |
| Grade 2-vs-Grade 4 |
6.08946226776652E-12 |
| Grade 3-vs-Grade 4 |
2.985900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.209600E-02 |
| Normal-vs-ccB subtype |
2.47729999958146E-07 |
| ccA subtype-vs-ccB subtype |
2.44249065417534E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.075900E-03 |
| Normal-vs-N1 |
2.661100E-03 |
| N0-vs-N1 |
4.711500E-02 |
|
|
